Now I have enough evidence from the medical library. Let me compose the comprehensive 25+ adult OPD case document using my strong clinical knowledge base, supplemented by what I retrieved.Here is a comprehensive educational reference covering 30 Adult OPD Cases with full clinical details and sample prescriptions:
30 Adult OPD Cases: Clinical Practice & Education Guide
Disclaimer: These are educational case templates for medical students, interns, and residents. All drug doses are for average adults with normal renal/hepatic function unless stated. Always individualize therapy. Sources: Goldman-Cecil Medicine, Textbook of Family Medicine 9e, Katzung Pharmacology 16e, Sleisenger & Fordtran GI 11e.
CARDIOVASCULAR CASES
CASE 1 - Essential Hypertension (Stage 1)
Patient: Mr. Ramesh K., 45 M, office worker
Chief Complaint: Headache, occasional dizziness for 3 months
History: Non-smoker. Father had hypertension. No chest pain, no shortness of breath. No prior medications.
Examination:
- BP: 148/94 mmHg (both arms, 2 readings, 5 min apart)
- HR: 82 bpm, regular
- BMI: 27.4 kg/m²
- Fundoscopy: Grade I arteriolar narrowing
- No pedal edema, normal heart sounds
Investigations:
- FBS: 95 mg/dL
- Lipid profile: LDL 138, HDL 42, TG 160
- Serum creatinine: 0.9 mg/dL, eGFR >60
- ECG: Normal sinus rhythm
- Urine R/E: No proteinuria
Diagnosis: Stage 1 Essential Hypertension (BP 140-159/90-99 mmHg)
Management Plan:
- Lifestyle: DASH diet, Na <1500 mg/day, aerobic exercise 90-150 min/week, alcohol restriction
- Start pharmacotherapy (ACC/AHA 2017: initiate if 10-yr ASCVD risk ≥10% or BP ≥140/90 with risk factors)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Ramesh K. Age: 45 M Date: __/__/____
Dx: Stage 1 Essential Hypertension
Rx:
1. Tab. AMLODIPINE 5 mg 1-0-0 × 30 days
(calcium channel blocker, first-line)
2. Tab. ASPIRIN 75 mg (Ecosprin) 0-0-1 × 30 days
(if 10-yr CVD risk ≥10%)
Advice:
• Monitor BP at home daily (morning + evening)
• DASH diet, reduce salt intake
• Walk 30 min daily
• Avoid NSAIDs/OCP without consultation
Review: 4 weeks with BP diary
══════════════════════════════════════════════════
Note: If BP not at goal (<130/80) in 4 weeks, add Tab. Losartan 50 mg OD or Telmisartan 40 mg OD.
CASE 2 - Essential Hypertension (Stage 2, diabetic patient)
Patient: Mrs. Sunita D., 54 F, housewife
Chief Complaint: Routine check-up, BP 160/100 found at pharmacy
History: Known T2DM on Metformin. No chest pain. Mild exertional dyspnea.
Examination:
- BP: 162/102 mmHg
- HR: 78, BMI: 29
- Mild ankle edema +
- S1 S2 normal, no murmurs
Investigations:
- HbA1c: 7.6%
- FBS: 148 mg/dL, PPBS: 210 mg/dL
- Urine microalbumin/creatinine ratio: 62 mg/g (elevated - early nephropathy)
- Creatinine: 1.1, eGFR 62 mL/min
- ECG: LVH by voltage criteria
Diagnosis: Stage 2 Hypertension + T2DM + Early Diabetic Nephropathy
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mrs. Sunita D. Age: 54 F Date: __/__/____
Dx: Stage 2 HTN + T2DM + Early Nephropathy
Rx:
1. Tab. TELMISARTAN 40 mg 1-0-0 × 30 days
(ARB - preferred in DM + proteinuria, renoprotective)
2. Tab. AMLODIPINE 5 mg 1-0-0 × 30 days
(synergistic with ARB for BP control)
3. Tab. METFORMIN 500 mg 1-0-1 with food × 30 days
(continue existing DM therapy)
4. Tab. ATORVASTATIN 20 mg 0-0-1 × 30 days
(high CV risk: statin indicated)
Advice:
• BP target: <130/80 mmHg (diabetic patient)
• Monitor serum creatinine and K+ in 2 weeks
• Protein restriction: 0.8 g/kg/day
• Foot care, eye examination due
Review: 2 weeks
══════════════════════════════════════════════════
CASE 3 - Stable Angina
Patient: Mr. Suresh P., 58 M, driver, smoker
Chief Complaint: Chest pain on exertion for 2 months, relieved by rest
History: Pain is retrosternal, radiates to left arm, lasts 3-5 min with exertion, relieved in 5 min by rest. No pain at rest. Smokes 15 cigarettes/day.
Examination:
- BP: 138/86, HR 80 bpm
- BMI: 26
- Normal heart sounds, no murmurs
Investigations:
- ECG: Normal at rest
- Stress ECG (TMT): ST depression 1.5 mm in leads V4-V6 at 7 METS - positive
- Lipids: LDL 168, HDL 38
- FBS: 102 mg/dL
- Troponin I: Negative
Diagnosis: Stable Angina Pectoris (CCS Grade II)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Suresh P. Age: 58 M Date: __/__/____
Dx: Stable Angina (CCS II)
Rx:
1. Tab. ASPIRIN 75 mg (Ecosprin) 1-0-0 × 30 days
2. Tab. ATENOLOL 50 mg 1-0-0 × 30 days
(beta-blocker: reduces HR, myocardial O₂ demand)
3. Tab. ISOSORBIDE MONONITRATE
SR 30 mg 1-0-0 × 30 days
(long-acting nitrate; give 8 AM to avoid nighttime hypotension)
4. Tab. ATORVASTATIN 40 mg 0-0-1 × 30 days
(target LDL <70 mg/dL in high CV risk)
5. GLYCERYL TRINITRATE (GTN)
spray 0.4 mg/puff PRN (1-2 puffs under tongue
during anginal episode)
Advice:
• Stop smoking IMMEDIATELY - most important
• Carry GTN spray at all times
• Avoid sudden heavy exertion
• Referred for Cardiology + Coronary angiography
Review: 2 weeks
══════════════════════════════════════════════════
ENDOCRINE / METABOLIC CASES
CASE 4 - Type 2 Diabetes Mellitus (Newly Diagnosed)
Patient: Mr. Vijay R., 48 M, software engineer
Chief Complaint: Increased thirst, frequent urination, fatigue × 3 months
History: Weight gain of 8 kg over 2 years. Father had diabetes. Sedentary lifestyle.
Examination:
- BMI: 31.2 (obese)
- BP: 132/84
- Acanthosis nigricans on neck
- No retinopathy, no peripheral neuropathy
Investigations:
- FBS: 176 mg/dL
- PPBS (2h post 75g): 265 mg/dL
- HbA1c: 8.2%
- Lipids: TG 218, HDL 38 (metabolic syndrome)
- Creatinine: 0.9, urine albumin: normal
- SGPT: 42 U/L (mild fatty liver)
Diagnosis: T2DM, newly diagnosed + Metabolic Syndrome
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Vijay R. Age: 48 M Date: __/__/____
Dx: Type 2 DM (newly diagnosed), HbA1c 8.2%
Rx:
1. Tab. METFORMIN 500 mg 1-0-1 (with meals) × 30 days
Titrate to 500 mg TDS after 2 weeks if tolerated
(first-line, weight-neutral, cardioprotective)
2. Tab. EMPAGLIFLOZIN 10 mg 1-0-0 (with breakfast) × 30 days
(SGLT2i: weight loss, BP reduction, renal/CV benefit)
3. Cap. OMEGA-3 FATTY ACIDS 1g 0-0-1 × 30 days
(for hypertriglyceridemia)
Advice:
• Target HbA1c: <7.0% (ADA 2024)
• SMBG: fasting + 2h post-prandial daily
• Calorie-restricted diet (1800 kcal/day)
• Walk 150 min/week
• Review in 3 months with HbA1c
Review: 3 months
══════════════════════════════════════════════════
CASE 5 - Hypothyroidism
Patient: Mrs. Priya M., 34 F, teacher
Chief Complaint: Weight gain, fatigue, cold intolerance, constipation, hair loss × 6 months
History: Heavy menstrual periods. Dry skin. Slow speech noted by family.
Examination:
- HR: 58 bpm (bradycardia)
- BP: 110/70
- Dry coarse skin, periorbital puffiness
- Goitre: Grade I (mild enlargement)
- Delayed ankle reflex relaxation (pathognomonic)
- BMI: 29
Investigations:
- TSH: 18.4 mIU/L (high) [Normal: 0.4-4.0]
- Free T4: 0.6 ng/dL (low) [Normal: 0.9-1.8]
- Anti-TPO antibodies: 640 IU/mL (positive - Hashimoto's)
- CBC: Hb 10.2 g/dL (normocytic anemia)
- Lipids: LDL 152, TG 188
Diagnosis: Primary Hypothyroidism (Hashimoto's Thyroiditis)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mrs. Priya M. Age: 34 F Date: __/__/____
Dx: Primary Hypothyroidism (Hashimoto's), TSH 18.4
Rx:
1. Tab. LEVOTHYROXINE (T4) 50 mcg 1-0-0
Take on EMPTY STOMACH, 30 min before breakfast
(Start low, titrate every 6 weeks based on TSH)
Advice:
• Do NOT take with calcium, iron, antacids (reduces absorption)
• Expected TSH goal: 0.5-2.5 mIU/L
• Symptoms improve in 4-8 weeks
• Lifelong therapy required
• Pregnancy: increase dose by 30%, notify doctor immediately
Review: 6 weeks with TSH, fT4
══════════════════════════════════════════════════
Dose guide: Starting dose = 1.6 mcg/kg/day (full replacement); start 25-50 mcg in elderly/cardiac patients.
CASE 6 - Hyperthyroidism (Graves' Disease)
Patient: Ms. Kavya S., 28 F, student
Chief Complaint: Weight loss despite good appetite, palpitations, heat intolerance, anxiety × 4 months
Examination:
- HR: 112 bpm, fine tremor of outstretched hands
- Exophthalmos (bilateral proptosis)
- Diffuse smooth goitre with bruit
- Warm, moist skin
- BP: 128/60 (wide pulse pressure)
Investigations:
- TSH: <0.01 mIU/L (suppressed)
- Free T4: 4.2 ng/dL (very high)
- Free T3: 12.1 pg/mL (high)
- TSH receptor antibodies (TRAb): Positive
- Thyroid uptake scan: Diffuse increased uptake
Diagnosis: Graves' Disease (Diffuse Toxic Goitre)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Ms. Kavya S. Age: 28 F Date: __/__/____
Dx: Graves' Disease (Hyperthyroidism)
Rx:
1. Tab. CARBIMAZOLE 20 mg 1-0-1 × 30 days
(antithyroid; titrate dose based on TFT)
2. Tab. PROPRANOLOL 40 mg 1-1-1 × 30 days
(beta-blocker: controls palpitations, tremor, heat intolerance)
(NOT definitive treatment, only symptomatic)
Advice:
• Report IMMEDIATELY if sore throat, fever, mouth ulcers
(agranulocytosis - rare but serious side effect of carbimazole)
• CBC + TFT in 4 weeks
• Discuss definitive options: Radioiodine (¹³¹I) or surgery
• Ophthalmology referral for exophthalmos
Review: 4 weeks
══════════════════════════════════════════════════
RESPIRATORY CASES
CASE 7 - Bronchial Asthma (Mild Persistent)
Patient: Mr. Ahmed K., 32 M, painter
Chief Complaint: Episodic wheezing, breathlessness, nocturnal cough × 1 year
History: Symptoms >2 days/week but not daily, nocturnal symptoms >2×/month. Uses Salbutamol inhaler PRN. Atopic (allergic rhinitis, eczema). No smoking.
Examination:
- RR: 18/min at rest
- SpO₂: 98% at rest
- Bilateral expiratory wheeze on auscultation during episode
- PEF: 78% predicted
Investigations:
- Spirometry: FEV1/FVC 68% (obstructive pattern)
- Post-bronchodilator FEV1 increase: 15% (reversibility confirmed)
- Skin prick test: Positive for house dust mite, pollen
- CBC: Eosinophilia (8%)
Diagnosis: Bronchial Asthma - Mild Persistent (GINA Step 2)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Ahmed K. Age: 32 M Date: __/__/____
Dx: Bronchial Asthma (Mild Persistent, GINA Step 2)
Rx:
1. BUDESONIDE 200 mcg MDI 2 puffs BD × 30 days
(inhaled corticosteroid - controller therapy)
Use spacer. Rinse mouth after each use.
2. SALBUTAMOL (Albuterol) 100 mcg MDI 2 puffs PRN
(SABA - reliever; use when symptomatic)
If using >2×/week, step up therapy
Advice:
• Demonstrate and check inhaler technique at each visit
• Avoid triggers: dust mites, cold air, paint fumes
• Allergen-proof mattress and pillow covers
• Asthma Action Plan provided (written)
• Avoid NSAIDs, beta-blockers (worsen asthma)
Review: 4-6 weeks
══════════════════════════════════════════════════
CASE 8 - COPD (Stable, Moderate)
Patient: Mr. Baldev S., 62 M, retired farmer, smoker 30 pack-years
Chief Complaint: Progressive breathlessness, productive cough for 5 years
History: Dyspnea on moderate exertion (mMRC Grade 2). Morning cough with whitish sputum. 2 exacerbations last year requiring antibiotics.
Examination:
- Barrel chest, reduced chest expansion
- Hyper-resonant percussion
- Reduced breath sounds bilaterally, prolonged expiration
- SpO₂: 93% at rest
- No cyanosis
Investigations:
- Spirometry: FEV1 52% predicted, FEV1/FVC 58% (post-BD, no significant reversibility) - GOLD Grade II
- CXR: Hyperinflation, flattened diaphragm
- ABG: pH 7.38, PaO₂ 68 mmHg, PaCO₂ 46 mmHg
- CBC: Polycythemia (Hb 17.2 g/dL)
Diagnosis: COPD - GOLD Group B (Moderate, High Symptom Burden)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Baldev S. Age: 62 M Date: __/__/____
Dx: COPD GOLD Group B (FEV1 52%, mMRC Grade 2)
Rx:
1. TIOTROPIUM 18 mcg HANDIHALER 1 capsule inhaled OD × 30 days
(LAMA - long-acting muscarinic antagonist, first-line)
2. SALMETEROL/FLUTICASONE
(Seretide) 25/250 mcg MDI 2 puffs BD × 30 days
(LABA + ICS - add for persistent symptoms)
3. SALBUTAMOL 100 mcg MDI 2 puffs PRN
(SABA - for rescue)
4. Tab. MUCOLYTIC (ERDOSTEINE 300mg) 1-0-1 × 15 days
(during winter/symptomatic periods)
Advice:
• SMOKING CESSATION is the single most important intervention
• Annual influenza vaccine, pneumococcal vaccine
• Pulmonary rehabilitation referral
• Supplemental O₂ if SpO₂ drops <88%
Review: 3 months or sooner if exacerbation
══════════════════════════════════════════════════
CASE 9 - Community-Acquired Pneumonia (CAP, Outpatient)
Patient: Ms. Deepa T., 38 F, nurse
Chief Complaint: Fever, cough with yellowish sputum, right-sided chest pain × 5 days
History: Chills, rigors on day 1. Pleuritic chest pain. No TB exposure. Vaccinated.
Examination:
- Temp: 38.8°C, RR: 22/min, HR: 98, BP: 118/76
- SpO₂: 96% on room air
- Right lower zone: dullness to percussion, increased vocal fremitus, bronchial breath sounds
Investigations:
- CBC: WBC 14,200 (neutrophilia)
- CXR: Right lower zone consolidation
- CRP: 64 mg/L
- PSI (PORT) Score: Class II (low severity, outpatient management)
- Sputum culture: Sent (Streptococcus pneumoniae expected)
Diagnosis: Community-Acquired Pneumonia (CAP) - Low Severity (Outpatient)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Ms. Deepa T. Age: 38 F Date: __/__/____
Dx: CAP (Low Severity, PORT Class II)
Rx:
1. Tab. AMOXICILLIN-CLAVULANATE
(Augmentin) 625 mg 1-0-1 × 7 days
(covers S.pneumoniae, H.influenzae, atypicals partially)
OR (if penicillin allergy):
Tab. AZITHROMYCIN 500 mg 1-0-0 × 5 days
2. Tab. PARACETAMOL 650 mg 1-1-1 (for fever) × 5 days
3. Syrup AMBROXOL 30 mg 1-1-1 × 5 days
(mucolytic, expectorant)
4. Tab. IBUPROFEN 400 mg 1-0-1 after food × 3 days
(for pleuritic pain)
Advice:
• Increase fluid intake (2-3 L/day)
• Return IMMEDIATELY if SpO₂ <94%, RR >30, confusion
• Rest for 5-7 days
• Repeat CXR at 6 weeks to confirm resolution
Review: 48-72 hours to reassess
══════════════════════════════════════════════════
GASTROINTESTINAL CASES
CASE 10 - Gastroesophageal Reflux Disease (GERD)
Patient: Mr. Ravi N., 44 M, IT professional
Chief Complaint: Heartburn, acid regurgitation after meals for 6 months, worse on bending/lying
History: Late-night meals, high coffee intake, sedentary. No dysphagia, no weight loss.
Examination:
- BMI: 28, epigastric mild tenderness
- No dysphagia, no hematemesis
Investigations:
- Upper GI endoscopy: Grade B esophagitis (LA classification - breaks >5 mm, not confluent)
- H. pylori rapid urease test: Negative
- Barium swallow: Free gastro-esophageal reflux
Diagnosis: GERD with Erosive Esophagitis (LA Grade B)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Ravi N. Age: 44 M Date: __/__/____
Dx: GERD (Erosive, LA Grade B)
Rx:
1. Tab. PANTOPRAZOLE 40 mg 1-0-0 (30 min before breakfast)
× 8 weeks
(PPI - gold standard; heals esophagitis in 4-8 weeks)
2. Syrup MAGALDRATE + SIMETHICONE 10 mL after meals + at bedtime
(antacid for symptomatic relief)
3. Tab. DOMPERIDONE 10 mg 1-1-1 (15 min before meals)
× 4 weeks
(prokinetic - reduces reflux episodes)
Advice:
• Elevate head of bed by 15-20 cm (use wedge, not extra pillows)
• Avoid coffee, chocolate, alcohol, mint, fatty foods, citrus
• No meals within 2-3 hours of bedtime
• Reduce weight (target BMI <25)
• Return if dysphagia, weight loss, hematemesis (red flags)
Review: 8 weeks (reassess need for long-term PPI)
══════════════════════════════════════════════════
Source: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, GERD section
CASE 11 - Peptic Ulcer Disease (H. pylori positive)
Patient: Mrs. Fatima B., 50 F
Chief Complaint: Epigastric pain relieved by food, nocturnal pain waking from sleep × 3 months
History: Regular NSAID use for knee pain.
Examination:
- Epigastric tenderness on deep palpation
- No guarding, no rebound
- No signs of perforation
Investigations:
- Endoscopy: 1.2 cm duodenal ulcer (D1), clean base
- Rapid urease test (CLO test): Positive for H. pylori
- Hb: 10.8 (mild anemia from occult blood loss)
Diagnosis: Duodenal Ulcer + H. pylori infection
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mrs. Fatima B. Age: 50 F Date: __/__/____
Dx: Duodenal Ulcer + H. pylori (CLO +ve)
Rx: (Triple Therapy - 14 days)
1. Tab. PANTOPRAZOLE 40 mg 1-0-1
2. Tab. CLARITHROMYCIN 500 mg 1-0-1
3. Tab. AMOXICILLIN 1 g 1-0-1
ALL × 14 DAYS (standard triple therapy)
Then:
4. Tab. PANTOPRAZOLE 40 mg 1-0-0 × 4 more weeks
(continue PPI after antibiotics for ulcer healing)
5. STOP NSAIDS. If essential:
Tab. CELECOXIB 200 mg + PPI (safer)
6. Tab. FERROUS FUMARATE 200 mg 1-0-1 × 30 days
(for anemia)
Advice:
• Test for H. pylori eradication 4 weeks AFTER completing antibiotics
(13C-urea breath test or stool antigen test)
• Avoid alcohol, smoking, NSAIDs
• Eat small, frequent meals; avoid spicy food
Review: 6 weeks
══════════════════════════════════════════════════
CASE 12 - Irritable Bowel Syndrome (IBS-D)
Patient: Ms. Meena R., 29 F, accountant
Chief Complaint: Alternating loose stools and constipation, bloating, abdominal cramps × 1 year
History: Symptoms related to stress. No blood in stool, no fever, no weight loss. Symptoms often relieved after defecation.
Examination:
- Mild left iliac fossa tenderness
- No organomegaly
- Per rectal: No mass
Investigations:
- CBC, CRP, ESR: Normal
- Thyroid function: Normal
- Stool routine/culture: Negative
- Colonoscopy (Rome IV criteria met, alarm features absent, age <45): Deferred
- Diagnosis: IBS-D (Diarrhea predominant, Rome IV criteria)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Ms. Meena R. Age: 29 F Date: __/__/____
Dx: IBS-D (Diarrhea predominant)
Rx:
1. Tab. MEBEVERINE 135 mg 1-0-1 (before meals) × 30 days
(antispasmodic - first-line for pain/cramping)
2. Tab. LOPERAMIDE 2 mg PRN (max 16 mg/day)
(for acute diarrheal episodes only)
3. Cap. LACTOBACILLUS (VSL#3 or
Sporlac DS) 1-0-1 × 30 days
(probiotics - shown to reduce IBS symptoms)
4. Tab. ESCITALOPRAM 5 mg 1-0-0 × 30 days
(low-dose SSRI for gut-brain axis; helps anxiety component)
Titrate to 10 mg after 2 weeks if tolerated.
Advice:
• Low-FODMAP diet trial (reduce wheat, dairy, legumes, onion, garlic)
• Identify and manage psychological stressors
• Cognitive Behavioral Therapy (CBT) referral
• Keep a food-symptom diary
Review: 4 weeks
══════════════════════════════════════════════════
MUSCULOSKELETAL CASES
CASE 13 - Rheumatoid Arthritis (Early, Active)
Patient: Mrs. Anjali K., 42 F
Chief Complaint: Bilateral hand joint pain and swelling, morning stiffness >1 hour × 8 months
History: Symmetric small joint involvement, fatigue, low-grade fever.
Examination:
- Bilateral MCP and PIP joint swelling (tender, warm)
- Morning stiffness: 90 minutes
- No deformities yet (early disease)
- DAS28 score: 4.8 (moderate disease activity)
Investigations:
- RF: Positive (1:640)
- Anti-CCP antibody: 85 U/mL (high positive - specific for RA)
- CRP: 42 mg/L, ESR: 78 mm/hr
- X-ray hands: Periarticular osteopenia, no erosions (early)
- CBC: Hb 10.4 (anemia of chronic disease)
Diagnosis: Rheumatoid Arthritis (Early, Moderate Activity)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mrs. Anjali K. Age: 42 F Date: __/__/____
Dx: Rheumatoid Arthritis (Early, DAS28: 4.8)
Rx:
1. Tab. METHOTREXATE 7.5 mg Once WEEKLY (Monday) × 4 weeks
(cDMARD - anchor drug; increase to 15 mg/wk in 4 weeks)
2. Tab. FOLIC ACID 5 mg 6 days/week (NOT on MTX day)
(prevents MTX side effects: stomatitis, nausea, cytopenias)
3. Tab. HYDROXYCHLOROQUINE 200 mg 1-0-1 × 30 days
(combination DMARD therapy)
4. Tab. PREDNISOLONE 10 mg 1-0-0 × 2 weeks
then taper to 5 mg × 2 weeks then stop
(bridge therapy while DMARDs take effect)
5. Tab. CALCIUM + VITAMIN D3
(Shelcal-CT) 1-0-1 × 30 days
(steroid-induced osteoporosis prevention)
Advice:
• Baseline: LFT, CBC, creatinine before MTX
• Monthly CBC + LFT while on MTX
• AVOID: alcohol (hepatotoxicity), NSAIDs (additive nephrotoxicity)
• Physiotherapy for hand exercises
• Ophthalmology baseline for hydroxychloroquine
Review: 4 weeks with labs
══════════════════════════════════════════════════
CASE 14 - Osteoarthritis (Knee)
Patient: Mr. Kiran B., 60 M, farmer
Chief Complaint: Bilateral knee pain, worse on standing/climbing stairs, stiffness <30 min after rest × 2 years
Examination:
- Crepitus on knee flexion/extension
- Bony enlargement (osteophytes) at knee margins
- Mild effusion right knee
- No warmth (cold joint)
- Quadriceps wasting
Investigations:
- X-ray knees: Joint space narrowing, osteophytes, subchondral sclerosis (K-L Grade III)
- ESR, CRP: Normal
- RA factor: Negative
- Uric acid: 5.2 mg/dL
Diagnosis: Bilateral Primary Osteoarthritis Knee (K-L Grade III)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Kiran B. Age: 60 M Date: __/__/____
Dx: Osteoarthritis Knee (K-L Grade III)
Rx:
1. Tab. PARACETAMOL 650 mg 1-1-1 after food × 14 days
(first-line analgesic for OA, safest)
2. Tab. ETORICOXIB 60 mg 1-0-0 after food × 14 days
(COX-2 inhibitor: better GI profile than NSAIDs)
Avoid if eGFR <30, cardiovascular disease
3. Cap. GLUCOSAMINE SULFATE 500 mg 1-1-1 × 90 days
+ CHONDROITIN 400 mg
(may slow progression, modest pain relief)
4. DICLOFENAC 1% GEL (topical) Apply to knee BD × 30 days
(topical NSAID: good local effect, minimal systemic effects)
5. INTRA-ARTICULAR HYALURONIC ACID (Durolane)
× 3 injections (if conservative management fails)
Advice:
• Quadriceps strengthening exercises (physiotherapy)
• Swimming, cycling preferred over running/squatting
• Unloader knee brace for medial compartment disease
• Weight loss to reduce joint load
• Refer orthopedics if Grade IV or functional impairment for TKR
Review: 4 weeks
══════════════════════════════════════════════════
CASE 15 - Gout (Acute Attack)
Patient: Mr. Vijesh T., 52 M, businessman
Chief Complaint: Sudden onset severe pain, redness, swelling right big toe since last night
History: Ate red meat and alcohol 2 nights ago. Previous similar episode 1 year ago.
Examination:
- First MTP joint: Hot, red, exquisitely tender, swollen (classic podagra)
- Temp: 37.8°C
- BP: 146/90
Investigations:
- Serum uric acid: 9.8 mg/dL (elevated)
- Joint aspirate: Negatively birefringent needle-shaped crystals (monosodium urate)
- WBC: 11,200 (mild leukocytosis)
- X-ray foot: Soft tissue swelling only (early/acute)
- Creatinine: 1.1 mg/dL
Diagnosis: Acute Gout (Podagra) - Acute Attack
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Vijesh T. Age: 52 M Date: __/__/____
Dx: Acute Gout (Podagra)
Rx: (Acute Attack - Phase 1):
1. Tab. INDOMETHACIN 50 mg 1-1-1 after food × 5 days
(NSAID of choice for acute gout; powerful anti-inflammatory)
OR Tab. ETORICOXIB 120 mg OD × 5 days
2. Tab. COLCHICINE 0.5 mg 1-0-1 × 5 days
(start within 24 hours of attack; very effective)
AVOID if CrCl <10 mL/min
3. Tab. PANTOPRAZOLE 40 mg 1-0-0 × 5 days
(GI protection with NSAID)
Phase 2 (Start 2-4 weeks AFTER acute attack resolves):
4. Tab. ALLOPURINOL 100 mg 1-0-0 × 30 days
(urate-lowering therapy; NEVER start during acute attack)
Titrate to 300 mg/day to target uric acid <6 mg/dL
Advice:
• Rest affected joint, elevate limb, ice pack
• Purine-restricted diet: avoid red meat, shellfish, organ meats
• Avoid alcohol (especially beer)
• Drink 2-3 L water daily
• Avoid aspirin, thiazide diuretics (raise uric acid)
Review: 2 weeks
══════════════════════════════════════════════════
NEUROLOGICAL CASES
CASE 16 - Migraine (Without Aura)
Patient: Ms. Pooja S., 26 F, student
Chief Complaint: Recurrent severe one-sided throbbing headache × 2 years, 3-4 episodes/month
History: Pain lasts 4-72 hours, associated with nausea, vomiting, photophobia, phonophobia. Worsens with activity. No visual aura. Family history (mother).
Examination:
- Normal neurological examination
- No papilledema
- No meningism
Investigations:
- MRI brain: Normal (done to exclude secondary cause)
- Diagnosis by ICHD-3 criteria (5+ attacks fulfilling criteria)
Diagnosis: Migraine Without Aura (ICHD-3)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Ms. Pooja S. Age: 26 F Date: __/__/____
Dx: Migraine Without Aura (3-4 attacks/month)
Rx: ACUTE (ABORTIVE) TREATMENT:
1. Tab. SUMATRIPTAN 50 mg 1 tablet at onset of attack
May repeat after 2 hrs if recurrence (max 200 mg/24h)
(triptan - gold standard for moderate-severe migraine)
2. Tab. DOMPERIDONE 10 mg 1-0-0 (with sumatriptan)
(antiemetic + hastens gastric emptying for better absorption)
3. Tab. IBUPROFEN 400 mg PRN (for mild attacks)
PREVENTIVE (given 3-4 attacks/month - threshold for prophylaxis):
4. Tab. PROPRANOLOL 40 mg 1-0-1 × 30 days
(first-line migraine prophylaxis; titrate to 80-160 mg/day)
AVOID in asthma
Advice:
• Headache diary: record triggers (sleep, stress, hormones, food)
• Avoid tyramine-rich foods, alcohol, caffeine excess
• Regular sleep schedule (irregular sleep is a major trigger)
• Avoid opioids (risk of medication overuse headache)
• Return if headache is worst ever, fever+neck stiffness, focal deficits
Review: 6 weeks
══════════════════════════════════════════════════
CASE 17 - Epilepsy (First Seizure, Generalized)
Patient: Mr. Arjun M., 24 M, college student
Chief Complaint: First episode of generalized tonic-clonic seizure lasting ~2 minutes yesterday
History: Post-ictal confusion for 30 min. No previous episodes. No head trauma, no family history.
Examination:
- Tongue bite, post-ictal (normal now)
- Neurological exam: Normal
- BP: 124/78
Investigations:
- MRI brain with contrast: Normal
- EEG: Generalized spike-wave discharges (2 Hz) - consistent with primary generalized epilepsy
- Metabolic panel: Normal glucose, electrolytes
- Drug/alcohol screen: Negative
Diagnosis: Generalized Epilepsy (Idiopathic)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Arjun M. Age: 24 M Date: __/__/____
Dx: Generalized Epilepsy
Rx:
1. Tab. SODIUM VALPROATE CR 500 mg 1-0-1 × 30 days
(first-line for generalized epilepsy; teratogenic - caution in females)
Titrate to 1000-2000 mg/day for seizure control
2. Tab. FOLIC ACID 5 mg 1-0-0 × ongoing
(if female of childbearing age on valproate)
Advice:
• Do NOT stop medication abruptly
• No driving for 6 months (as per local regulations)
• Avoid alcohol, sleep deprivation (major seizure triggers)
• Monitor LFT, CBC at baseline and every 6 months
• Serum valproate level in 4 weeks (therapeutic: 50-100 mcg/mL)
• INFORM family about seizure first aid (lateral position, DO NOT restrain)
Review: 4 weeks
══════════════════════════════════════════════════
PSYCHIATRIC / PSYCHOSOMATIC CASES
CASE 18 - Major Depressive Disorder
Patient: Mrs. Lalitha P., 38 F
Chief Complaint: Persistent low mood, loss of interest in activities, fatigue × 6 weeks
History: Insomnia (early morning waking), poor appetite, weight loss 4 kg, difficulty concentrating, feelings of worthlessness. PHQ-9 score: 18 (moderately severe).
Examination:
- Psychomotor retardation
- Flat affect
- No suicidal ideation (screen negative with Columbia Suicide Severity Rating Scale)
- Thyroid/metabolic exam: Normal
Investigations:
- TSH: Normal (rule out hypothyroidism)
- CBC, LFT, RFT: Normal
- PHQ-9: 18 (moderately severe depression)
Diagnosis: Major Depressive Disorder (Moderate-Severe, single episode)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mrs. Lalitha P. Age: 38 F Date: __/__/____
Dx: Major Depressive Disorder (PHQ-9: 18)
Rx:
1. Tab. ESCITALOPRAM 10 mg 1-0-0 (morning) × 30 days
(SSRI - first-line; full effect in 4-6 weeks)
May increase to 20 mg after 4 weeks if needed
2. Tab. CLONAZEPAM 0.5 mg 0-0-1 × 2 weeks only
(short-term for severe insomnia/anxiety; avoid long-term use)
Advice:
• Psychotherapy (CBT) referral strongly recommended
• Full course required: minimum 6-9 months
• Do NOT stop medication abruptly (discontinuation syndrome)
• Exercise 30 min daily (proven antidepressant effect)
• Suicidal ideation: go to ER immediately
• Side effects: Initial nausea/insomnia improves in 1-2 weeks
Review: 2 weeks (then monthly)
══════════════════════════════════════════════════
CASE 19 - Generalized Anxiety Disorder (GAD)
Patient: Mr. Rohit K., 31 M, marketing manager
Chief Complaint: Excessive worry about work/finances, restlessness, muscle tension, poor sleep × 6 months
History: Difficulty controlling worry, irritable, can't concentrate. GAD-7 score: 14 (moderate).
Examination:
- Mildly elevated BP (138/88), tachycardia (HR 96)
- Physical examination otherwise normal
- No thyroid enlargement
Investigations:
- TSH: Normal, CBC: Normal
- ECG: Sinus tachycardia, no arrhythmia
- GAD-7: 14 (moderate)
Diagnosis: Generalized Anxiety Disorder (DSM-5)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Rohit K. Age: 31 M Date: __/__/____
Dx: Generalized Anxiety Disorder (GAD-7: 14)
Rx:
1. Tab. SERTRALINE 50 mg 1-0-0 (with food) × 30 days
(SSRI - first-line for GAD)
2. Tab. BUSPIRONE 10 mg 1-0-1 × 30 days
(non-benzodiazepine anxiolytic; take 2-4 weeks for effect)
Advice:
• CBT is as effective as medications - refer
• Avoid benzodiazepines for long-term use (dependence)
• Mindfulness-based stress reduction (MBSR) techniques
• Limit caffeine, alcohol
• Exercise regularly
• Sleep hygiene education
Review: 4 weeks
══════════════════════════════════════════════════
UROLOGICAL / NEPHROLOGY CASES
CASE 20 - Urinary Tract Infection (Uncomplicated, Female)
Patient: Ms. Ananya G., 22 F, college student
Chief Complaint: Burning micturition, frequency, urgency × 2 days
History: No fever, no loin pain, no vaginal discharge. Sexually active. No previous UTI.
Examination:
- Suprapubic tenderness
- No costovertebral angle tenderness (no pyelonephritis)
- Temp: 37.1°C
Investigations:
- Urine R/E: Pyuria (>10 WBC/HPF), bacteria +++
- Urine culture: E. coli >10⁵ CFU/mL (sent before starting antibiotics)
- Pregnancy test: Negative
Diagnosis: Uncomplicated Cystitis (UTI)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Ms. Ananya G. Age: 22 F Date: __/__/____
Dx: Uncomplicated UTI (Acute Cystitis)
Rx:
1. Tab. NITROFURANTOIN 100 mg MR 1-0-1 with food × 5 days
(first-line, high urinary concentration, low resistance)
OR Tab. TRIMETHOPRIM 200 mg 1-0-1 × 3 days
(if local resistance <20%)
OR Tab. FOSFOMYCIN 3g Single dose
(single dose regimen, excellent compliance)
2. Tab. PHENAZOPYRIDINE 200 mg 1-1-1 × 2 days only
(urinary analgesic - relieves burning urgency quickly)
WARN: turns urine orange-red (not blood)
3. Tab. PARACETAMOL 500 mg PRN for pain
Advice:
• Complete full antibiotic course
• Drink 2-3 L water daily
• Urinate after sexual intercourse
• Wipe front to back
• Return if fever develops, loin pain (possible pyelonephritis)
Review: 5 days (with culture and sensitivity report)
══════════════════════════════════════════════════
CASE 21 - Benign Prostatic Hyperplasia (BPH)
Patient: Mr. Narayana R., 67 M
Chief Complaint: Weak urinary stream, hesitancy, nocturia × 2, incomplete emptying × 18 months
History: IPSS (International Prostate Symptom Score): 18 (moderate)
Examination:
- DRE (Digital Rectal Exam): Smooth, enlarged prostate (~40 mL), non-tender, no hard nodules
- No pedal edema
Investigations:
- PSA: 2.8 ng/mL (slightly elevated; age-adjusted normal)
- USG abdomen: Prostate 42 mL, post-void residual 110 mL
- Creatinine: 1.0 (no obstructive uropathy)
- Urine culture: Sterile
Diagnosis: Benign Prostatic Hyperplasia (Moderate LUTS)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Narayana R. Age: 67 M Date: __/__/____
Dx: BPH (IPSS 18, prostate 42 mL)
Rx:
1. Tab. TAMSULOSIN 0.4 mg 0-0-1 (after dinner) × 30 days
(alpha-1 blocker: relaxes prostate/bladder neck smooth muscle)
Side effect: retrograde ejaculation, orthostatic hypotension
2. Tab. FINASTERIDE 5 mg 0-0-1 × 30 days
(5-alpha reductase inhibitor: shrinks prostate; takes 3-6 months)
Combined alpha-blocker + 5ARI: better for large prostates
Advice:
• Avoid: alcohol, coffee, cold medicines (decongestants worsen symptoms)
• Limit fluids in evenings, empty bladder before bed
• Annual PSA monitoring
• Urology referral if PSA rising, post-void residual >300 mL, recurrent UTI
• Side effect: Finasteride causes decreased libido, impotence in ~4%
Review: 3 months with repeat IPSS + PSA
══════════════════════════════════════════════════
HEMATOLOGICAL CASES
CASE 22 - Iron Deficiency Anemia
Patient: Mrs. Rekha S., 30 F, housewife
Chief Complaint: Fatigue, pallor, breathlessness on exertion, craving to eat clay × 2 months
History: Menorrhagia (heavy periods, 7-8 days), 3 pregnancies, poor diet.
Examination:
- Pallor (conjunctival, palmar, mucosal)
- Koilonychia (spoon-shaped nails)
- Angular stomatitis, glossitis
- HR: 102 bpm, no cardiac murmur
Investigations:
- Hb: 7.8 g/dL
- MCV: 64 fL (microcytic), MCH: 18 pg (hypochromic)
- Serum ferritin: 6 ng/mL (very low; most specific for iron deficiency)
- Serum iron: 42 mcg/dL (low), TIBC: 480 mcg/dL (high)
- Peripheral smear: Microcytic hypochromic RBCs, pencil cells, target cells
Diagnosis: Iron Deficiency Anemia (severe) due to Menorrhagia
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mrs. Rekha S. Age: 30 F Date: __/__/____
Dx: Iron Deficiency Anemia (Hb 7.8, Ferritin 6)
Rx:
1. Tab. FERROUS SULFATE 200 mg 1-0-1 (empty stomach or with juice)
× 90 days
(provides 60 mg elemental iron/tablet; continue 3 months
after Hb normalizes to replenish stores)
2. Tab. VITAMIN C 500 mg 1-0-1 (WITH iron tablet)
(enhances iron absorption by 30%)
3. Tab. FOLIC ACID 5 mg 1-0-0 × 90 days
Gynaecology referral for menorrhagia management:
4. Tab. TRANEXAMIC ACID 500 mg 1-1-1 during periods × 5 days
(antifibrinolytic to reduce menstrual blood loss)
Advice:
• Iron: take 1 hour before or 2 hours after meals
• Avoid with tea, coffee, milk (inhibit absorption)
• Black/dark stools - normal with iron therapy
• Expected Hb rise: 1-2 g/dL per week
• Reticulocyte count peaks at day 7-10 (confirms response)
Review: 4 weeks with CBC
══════════════════════════════════════════════════
CASE 23 - Vitamin B12 Deficiency (Megaloblastic Anemia)
Patient: Mr. Thomas V., 55 M, strict vegetarian
Chief Complaint: Fatigue, tingling/numbness in hands and feet, difficulty walking × 1 year
History: Strict vegan diet for 10 years. No GI surgery. Mild memory issues.
Examination:
- Pallor, lemon-yellow tinge to skin
- Glossitis (beefy red tongue)
- Loss of vibration sense and proprioception (posterior column signs)
- Romberg's test: Positive
Investigations:
- Hb: 8.6 g/dL, MCV: 112 fL (macrocytic)
- Peripheral smear: Macro-ovalocytes, hypersegmented neutrophils (>5 lobes)
- Serum B12: 78 pg/mL (low; Normal >200 pg/mL)
- Serum folate: Normal
- Homocysteine: Elevated (68 mcmol/L)
- Intrinsic factor antibodies: Sent
Diagnosis: Vitamin B12 Deficiency (Megaloblastic Anemia + Subacute Combined Degeneration)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Thomas V. Age: 55 M Date: __/__/____
Dx: B12 Deficiency Anemia + Neurological involvement
Rx:
1. Inj. CYANOCOBALAMIN (B12) 1000 mcg IM
Daily × 7 days, then weekly × 4 weeks,
then monthly for life
(IM route essential if neurological involvement or pernicious anemia)
After loading:
2. Tab. METHYLCOBALAMIN 1500 mcg 1-0-0 × ongoing
(oral maintenance for dietary deficiency without pernicious anemia)
3. Tab. FOLIC ACID 5 mg 1-0-0 × 30 days
(ALWAYS give B12 first before folate to avoid masking
B12 deficiency and worsening neuropathy)
4. Cap. PREGABALIN 75 mg 0-0-1 × 30 days
(for neuropathic pain/tingling)
Advice:
• Neurological recovery: months to years; Hb normalizes in 6-8 weeks
• Reticulocyte crisis at day 7-10 (expected, good sign)
• Dietary B12 sources: meat, eggs, dairy, fortified cereals
• Lifelong supplementation if pernicious anemia confirmed
Review: 4 weeks with CBC
══════════════════════════════════════════════════
DERMATOLOGICAL CASES
CASE 24 - Psoriasis (Plaque Type, Mild-Moderate)
Patient: Mr. Manish G., 35 M
Chief Complaint: Scaly, itchy red patches on elbows, knees, scalp × 3 years
History: Family history (father). Exacerbated by stress, streptococcal throat infections. Nail pitting noted.
Examination:
- Well-demarcated erythematous plaques with silvery-white scales on extensor surfaces
- Auspitz sign: Positive (pinpoint bleeding on scale removal)
- Nail changes: Pitting, onycholysis
- PASI score: 8 (moderate)
- No joint involvement
Investigations:
- Clinical diagnosis (biopsy if atypical: parakeratosis, acanthosis, Munro microabscesses)
- ASO titer: 320 (recent strep infection trigger)
- Throat swab: Group A Streptococcus
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Manish G. Age: 35 M Date: __/__/____
Dx: Plaque Psoriasis (PASI 8, moderate)
Rx:
1. CALCIPOTRIOL 0.005% ointment Apply BD to plaques × 4 weeks
(vitamin D analog - first-line topical)
2. BETAMETHASONE DIPROPIONATE 0.05% ointment
Apply OD (evenings) × 2 weeks
(potent topical steroid; limited use to avoid atrophy)
COMBINATION (Daivobet = calcipotriol + betamethasone) is more effective
3. SALICYLIC ACID 6% ointment Apply to thick plaques OD × 2 weeks
(keratolytic - softens scale before steroid)
4. For scalp psoriasis:
CLOBETASOL PROPIONATE 0.05% shampoo/lotion
Apply to scalp, leave 15 min, wash × alternate days
5. Tab. CETIRIZINE 10 mg 0-0-1 × 30 days
(for pruritus)
6. EMOLLIENT (white soft paraffin/Vaseline) apply frequently
(moisturize to prevent fissuring)
Advice:
• Avoid scratching (Koebner phenomenon - new lesions at trauma sites)
• Sun exposure in moderation (beneficial for psoriasis)
• Stress management
• Dermatology referral if PASI >10 or not responding
(systemic therapy: methotrexate, cyclosporine, biologics)
Review: 4 weeks
══════════════════════════════════════════════════
CASE 25 - Acne Vulgaris (Moderate)
Patient: Ms. Shruti R., 19 F, college student
Chief Complaint: Facial acne, blackheads, painful pimples × 2 years, worsening perimenstrually
History: Oily skin. Previous use of OTC benzoyl peroxide with partial response.
Examination:
- Comedones (open + closed), inflammatory papules, pustules on face, chest, back
- Few nodules on jaw line
- No cysts/scars (not severe)
- GAGS (Global Acne Grading Score): 24 (moderate)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Ms. Shruti R. Age: 19 F Date: __/__/____
Dx: Acne Vulgaris (Moderate, GAGS 24)
Rx:
1. ADAPALENE 0.1% gel Apply to entire face ON × 8 weeks
(retinoid - unclogs pores, reduces comedones)
Apply at night, use sunscreen in morning
2. CLINDAMYCIN 1% + BENZOYL
PEROXIDE 5% gel (Duac/Epiduo) Apply BD × 8 weeks
(topical antibiotic + BPO: prevents resistance)
3. Tab. DOXYCYCLINE 100 mg 1-0-0 after food × 6 weeks
(oral antibiotic for inflammatory acne)
Take with water, remain upright for 30 min (avoid esophagitis)
Avoid sun exposure (photosensitivity)
4. Tab. CYPROTERONE/ETHINYL
ESTRADIOL (Diane-35) 1-0-0 (if on contraception,
hormonal acne in females)
(anti-androgenic OCP for perimenstrual flares)
Advice:
• Gentle non-comedogenic face wash BD
• Oil-free, non-comedogenic moisturizer + SPF 30 sunscreen
• Do NOT squeeze/pick lesions (scarring)
• Full response takes 8-12 weeks; do not abandon treatment early
• If not improving in 3 months - refer to dermatologist for isotretinoin
Review: 8 weeks
══════════════════════════════════════════════════
OPHTHALMOLOGICAL / ENT CASES
CASE 26 - Allergic Rhinitis (Perennial)
Patient: Mr. Sanjay K., 28 M, teacher
Chief Complaint: Nasal congestion, sneezing, runny nose, itchy eyes throughout the year × 3 years
History: Worse at home (dust mites). Atopic (also has mild asthma). No polyps on previous scoping.
Examination:
- Pale, boggy nasal mucosa
- Allergic shiners (dark circles under eyes)
- Transverse nasal crease (salute sign)
- Anterior rhinoscopy: Clear discharge, no polyps
Investigations:
- Skin prick test: Positive for house dust mite, Aspergillus
- IgE total: 480 IU/mL (high)
- Nasal smear: Eosinophilia
Diagnosis: Perennial Allergic Rhinitis (Moderate-Severe, ARIA classification)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Sanjay K. Age: 28 M Date: __/__/____
Dx: Perennial Allergic Rhinitis (Moderate-Severe)
Rx:
1. MOMETASONE FUROATE (Nasonex) 50 mcg nasal spray
2 sprays each nostril OD × 30 days
(intranasal corticosteroid - most effective single agent;
onset: 1-2 weeks)
2. Tab. FEXOFENADINE 180 mg 1-0-0 × 30 days
(non-sedating antihistamine for itching, sneezing)
3. OLOPATADINE 0.1% eye drops 1 drop each eye BD × 30 days
(for allergic conjunctivitis)
4. NASAL SALINE IRRIGATION (Neti pot / SinuRinse)
BD × ongoing
(washes out allergens from nasal mucosa)
Advice:
• Allergen-proof mattress and pillow covers
• Regular vacuuming with HEPA filter
• Avoid pets (if allergic)
• Consider sublingual immunotherapy if inadequate response
• ENT referral to exclude nasal polyps / deviated septum
Review: 4 weeks
══════════════════════════════════════════════════
CASE 27 - Acute Pharyngotonsillitis
Patient: Ms. Nandini P., 22 F
Chief Complaint: Sore throat, fever, difficulty swallowing × 3 days
History: No cough. Exposure to a friend with similar illness.
Examination:
- Temp: 38.6°C
- Tonsils: Enlarged (Grade III), erythematous, white exudate on tonsils
- Tender anterior cervical lymphadenopathy
- No cough
- Centor Score: 4 (exudate + tender nodes + fever + no cough = high probability Group A Strep)
Investigations:
- Rapid Strep Antigen Test: Positive
- Monospot test: Negative (exclude EBV mononucleosis)
- CBC: WBC 14,500 (neutrophilia)
Diagnosis: Streptococcal Tonsillitis (Group A Beta-haemolytic Streptococcus)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Ms. Nandini P. Age: 22 F Date: __/__/____
Dx: Streptococcal Tonsillitis (Centor 4, Rapid Strep +)
Rx:
1. Tab. AMOXICILLIN 500 mg 1-1-1 × 10 days
(first-line: must complete full 10 days to prevent
rheumatic fever)
If penicillin allergy:
Tab. AZITHROMYCIN 500 mg OD × 5 days
2. Tab. PARACETAMOL 650 mg 1-1-1 × 5 days
(fever and pain relief)
3. Tab. IBUPROFEN 400 mg 1-0-1 after food × 5 days
(reduces tonsillar inflammation)
4. BENZYDAMINE (Tantum Verde)
gargle / spray Use every 3-4 hours
(local anti-inflammatory gargle)
Advice:
• Warm salt water gargles
• Soft/liquid diet, good hydration
• Complete antibiotic course even if feeling better
• Contact precautions: cover mouth, separate utensils
• Return if unable to swallow/drool, trismus, muffled voice
(peritonsillar abscess - emergency)
Review: 5 days if not improving
══════════════════════════════════════════════════
ORTHOPEDIC CASES
CASE 28 - Low Back Pain (Non-specific, Acute)
Patient: Mr. Deepak S., 40 M, software developer
Chief Complaint: Sudden-onset lower back pain since bending to pick up object yesterday; pain 7/10
History: No radiation to legs, no neurological symptoms. Sedentary desk job. First episode.
Red flag screen: No fever, no weight loss, no bladder/bowel dysfunction, no night pain, no trauma.
Examination:
- Lumbar muscle spasm, tenderness over L4-L5 paravertebral muscles
- Forward flexion limited (pain)
- SLR (Straight Leg Raise): Negative bilaterally
- Normal lower limb neurology
Investigations:
- X-ray lumbosacral spine: No fracture, mild lumbar spondylosis
- (MRI NOT indicated in absence of red flags for first episode <6 weeks)
Diagnosis: Acute Non-Specific Low Back Pain
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Deepak S. Age: 40 M Date: __/__/____
Dx: Acute Non-Specific Low Back Pain
Rx:
1. Tab. IBUPROFEN 400 mg 1-1-1 after food × 7 days
(NSAID - first-line for acute LBP)
2. Tab. THIOCOLCHICOSIDE 4 mg 1-0-1 × 5 days
(muscle relaxant for spasm; do not drive)
3. Tab. PANTOPRAZOLE 40 mg 1-0-0 × 7 days
(GI protection with NSAID)
4. DICLOFENAC SODIUM EMULGEL 1% Apply to lower back BD-TDS
(topical NSAID)
Advice:
• Bed rest NOT recommended (active movement heals faster)
• Continue light activity as tolerated
• Hot pack application to lower back
• McKenzie exercises (physiotherapy)
• Ergonomic assessment of workstation
• Most acute LBP resolves in 4-6 weeks
• Return if numbness/weakness in legs, bladder/bowel changes
Review: 2 weeks
══════════════════════════════════════════════════
INFECTIOUS DISEASE CASES
CASE 29 - Pulmonary Tuberculosis (New Case)
Patient: Mr. Sami A., 30 M, migrant worker
Chief Complaint: Cough >3 weeks, hemoptysis, evening fever, night sweats, weight loss × 2 months
History: Close contact with TB patient (room-mate). Non-smoker.
Examination:
- Wasted, pale
- Temp: 37.9°C (evening)
- Right upper zone: Dullness, crepitations
- Weight: 52 kg (BMI 17.8)
Investigations:
- Sputum AFB smear: 3+ (highly positive)
- GeneXpert MTB/RIF: MTB detected, Rifampicin sensitive
- CXR: Right upper lobe fibro-cavitary infiltrates
- HIV test: Negative (mandatory co-testing)
- LFT: Normal (baseline before starting HRZE)
- Uric acid: 5.1 mg/dL (baseline for pyrazinamide)
Diagnosis: Pulmonary TB (Sputum Positive, New Case, Drug-Sensitive)
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
══════════════════════════════════════════════════
Pt: Mr. Sami A. Age: 30 M Wt: 52 kg Date: __/__/____
Dx: Pulmonary TB (SS+, New Case)
Rx: (As per WHO/RNTCP 2022 guidelines)
INTENSIVE PHASE (2 months): HRZE
1. Tab. ISONIAZID (H) 300 mg OD (fasting)
2. Tab. RIFAMPICIN (R) 450 mg OD (fasting, <50 kg)
3. Tab. PYRAZINAMIDE (Z) 1500 mg OD
4. Tab. ETHAMBUTOL (E) 800 mg OD
[All 4 drugs given as fixed-dose combination: 4-drug FDC tablet]
5. Tab. PYRIDOXINE (B6) 25 mg OD
(prevents INH-induced peripheral neuropathy)
CONTINUATION PHASE (4 months): HR
6. Tab. ISONIAZID 300 mg OD
7. Tab. RIFAMPICIN 450 mg OD
(2-drug FDC for 4 months)
Advice:
• Notify health authorities (notifiable disease)
• Daily observed therapy (DOT) preferred
• Isolate until sputum smear negative
• Contact tracing: household contacts for LTBI
• WARN: rifampicin turns urine/secretions orange-red (normal)
• Monthly LFT monitoring; stop if bilirubin/enzymes rise >3x ULN
• No alcohol (hepatotoxicity)
Review: Monthly with sputum AFB, LFT
══════════════════════════════════════════════════
GERIATRIC / MULTIMORBIDITY CASE
CASE 30 - Polypharmacy / Multimorbidity Review (Elderly Patient)
Patient: Mr. Krishnamurthy R., 72 M
Chief Complaint: Follow-up for multiple conditions; dizziness, fall last week
History: T2DM, HTN, hypothyroidism, GERD, knee OA, benign prostate, depression.
Current Medications (brought to clinic):
Metformin, Glibenclamide, Amlodipine, Enalapril, Levothyroxine, Omeprazole, Diclofenac, Tamsulosin, Alprazolam
Examination:
- BP lying: 138/80; Standing: 108/68 (orthostatic hypotension - cause of falls)
- HR: 58 bpm
- Postural sway on Romberg's
Issues identified (Medication Review using Beers Criteria 2023):
- Glibenclamide - HIGH RISK in elderly (prolonged hypoglycemia) - STOP
- Diclofenac - HIGH RISK in elderly (GI bleed, renal impairment, fluid retention) - STOP
- Alprazolam - HIGH RISK in elderly (falls, cognitive impairment) - TAPER and STOP
- Enalapril + Tamsulosin + Amlodipine - triple antihypertensive contributing to orthostatic hypotension
- Omeprazole long-term - consider stopping/stepping down if no active GERD
══════════════════════════════════════════════════
OUTPATIENT DEPARTMENT PRESCRIPTION
(Polypharmacy Review / Medication Optimization)
══════════════════════════════════════════════════
Pt: Mr. Krishnamurthy R. Age: 72 M Date: __/__/____
Dx: Multimorbidity + Polypharmacy + Falls Risk
STOP:
- GLIBENCLAMIDE → Replace with Tab. SITAGLIPTIN 100 mg OD
(safer DPP-4i in elderly, no hypoglycemia risk)
- DICLOFENAC → Replace with PARACETAMOL 500 mg + TOPICAL NSAID
- ALPRAZOLAM → Taper: halve dose every 2 weeks then stop
Replace with Tab. MIRTAZAPINE 7.5 mg nocte
(treats depression + improves sleep, no falls risk)
CONTINUE:
- Tab. METFORMIN 500 mg BD
- Tab. AMLODIPINE 5 mg OD
- Tab. LEVOTHYROXINE 50 mcg OD (morning, fasting)
- Tab. TAMSULOSIN 0.4 mg OD (for BPH)
REDUCE RISK:
- REDUCE ENALAPRIL to 5 mg (from 10 mg) to address orthostatic hypotension
- Tab. RABEPRAZOLE 20 mg OD only 3 days/week (PRN stepping down)
ADD:
- Tab. CALCIUM 500 mg + VITAMIN D3 1000 IU OD
- FALL PREVENTION: home assessment, grab rails, night light
Advice:
• Medication reconciliation list given to patient and family
• Falls risk assessment
• Physiotherapy + balance training
• Re-check BP lying and standing in 2 weeks
• Brown bag review every 6 months
Review: 2 weeks
══════════════════════════════════════════════════
QUICK REFERENCE SUMMARY TABLE
| # | Case | Key Drug Class | Key Drug | Duration |
|---|
| 1 | Hypertension Stage 1 | CCB | Amlodipine 5 mg | Long-term |
| 2 | HTN + DM + Nephropathy | ARB | Telmisartan 40 mg | Long-term |
| 3 | Stable Angina | Beta-blocker + Nitrate | Atenolol + ISDN | Long-term |
| 4 | T2DM (new) | Biguanide + SGLT2i | Metformin + Empagliflozin | Long-term |
| 5 | Hypothyroidism | Thyroid hormone | Levothyroxine 50 mcg | Lifelong |
| 6 | Graves' Disease | Antithyroid | Carbimazole 20 mg | 12-18 months |
| 7 | Asthma (mild persistent) | ICS + SABA | Budesonide + Salbutamol | Long-term |
| 8 | COPD (moderate) | LAMA + LABA/ICS | Tiotropium + Salmeterol/Fluticasone | Long-term |
| 9 | Pneumonia (CAP, outpatient) | Aminopenicillin | Amoxicillin-Clavulanate | 7 days |
| 10 | GERD (erosive) | PPI | Pantoprazole 40 mg | 8 weeks |
| 11 | Peptic Ulcer + H. pylori | Triple therapy | PPI + Clarithromycin + Amoxicillin | 14 days |
| 12 | IBS-D | Antispasmodic | Mebeverine 135 mg | 30 days |
| 13 | Rheumatoid Arthritis | cDMARD | Methotrexate + Hydroxychloroquine | Long-term |
| 14 | Osteoarthritis Knee | COX-2 inhibitor | Etoricoxib 60 mg | Short courses |
| 15 | Gout (acute) | NSAID + Colchicine | Indomethacin + Colchicine | 5 days acute |
| 16 | Migraine | Triptan | Sumatriptan 50 mg | PRN |
| 17 | Epilepsy (generalized) | Anticonvulsant | Sodium Valproate CR 500 mg | Long-term |
| 18 | Depression (MDD) | SSRI | Escitalopram 10 mg | 6-9 months |
| 19 | Anxiety (GAD) | SSRI | Sertraline 50 mg | 6-12 months |
| 20 | UTI (uncomplicated) | Nitrofurantoin | Nitrofurantoin 100 mg MR | 5 days |
| 21 | BPH | Alpha-blocker + 5-ARI | Tamsulosin + Finasteride | Long-term |
| 22 | Iron Deficiency Anemia | Iron supplement | Ferrous Sulfate 200 mg | 90 days |
| 23 | B12 Deficiency | Cobalamin | Cyanocobalamin IM 1000 mcg | Lifelong |
| 24 | Psoriasis (plaque) | Vitamin D analog | Calcipotriol 0.005% oint. | 4 weeks |
| 25 | Acne Vulgaris (moderate) | Retinoid + Antibiotic | Adapalene + Doxycycline | 6-8 weeks |
| 26 | Allergic Rhinitis | Intranasal steroid | Mometasone nasal spray | Long-term |
| 27 | Streptococcal Tonsillitis | Penicillin | Amoxicillin 500 mg | 10 days |
| 28 | Low Back Pain (acute) | NSAID + Muscle relaxant | Ibuprofen + Thiocolchicoside | 7 days |
| 29 | Pulmonary TB | HRZE regimen | 4-drug FDC | 6 months |
| 30 | Polypharmacy (elderly) | Medication review | De-prescribing (Beers criteria) | Ongoing |
KEY PRESCRIBING PRINCIPLES (OPD Practice)
1. Before writing any prescription:
- Check allergies and document
- Check renal function (eGFR) before NSAIDs, metformin, methotrexate, nitrofurantoin
- Check LFT before hepatotoxic drugs (methotrexate, anti-TB, statins)
- Pregnancy status before tetracyclines, retinoids, warfarin, valproate, methotrexate
2. Prescription format essentials:
- Drug name (generic preferred), dose, route, frequency, duration
- Special instructions (empty stomach, after food, at night, with water)
- Specific warnings (driving, photosensitivity, colour changes in urine)
- Review date
3. Red flag symptoms requiring urgent referral:
| System | Red Flags |
|---|
| GI | Dysphagia, hematemesis, weight loss, jaundice |
| Respiratory | Hemoptysis, SpO₂ <94%, stridor |
| Cardiovascular | Chest pain at rest, severe hypertension (>180/120) |
| Neurological | First/worst ever headache, focal deficits, altered consciousness |
| Musculoskeletal | Night pain, weight loss with bone pain, pathological fracture |
4. Monitoring schedule for common drugs:
| Drug | Monitoring |
|---|
| Metformin | Creatinine annually (hold if eGFR <30) |
| Methotrexate | CBC + LFT monthly |
| Carbimazole | CBC + TFT 4-6 weekly (watch for agranulocytosis) |
| Levothyroxine | TSH every 6 weeks until stable, then annually |
| Anti-TB drugs (HRZE) | LFT, uric acid (PZA), visual acuity (ethambutol) monthly |
| ACE inhibitors/ARBs | Creatinine + K+ in 2 weeks after starting |
| Sodium Valproate | LFT, CBC, drug levels every 6 months |
Sources: Goldman-Cecil Medicine (International Edition), Textbook of Family Medicine 9e (Rakel), Katzung Basic & Clinical Pharmacology 16e, Sleisenger & Fordtran's Gastrointestinal & Liver Disease, WHO Essential Medicines guidelines, ACC/AHA 2017 HTN Guidelines, GINA 2023, GOLD 2024, ADA 2024, RNTCP/WHO TB guidelines 2022.
---Here is a complete summary of what was covered:
What You Got: 30 Adult OPD Cases for Practice & Education
All 30 cases include: Patient demographics → Chief complaint → History → Physical examination → Investigations with results → Diagnosis → Sample prescription → Patient advice → Review schedule
Cases by System:
| System | Cases |
|---|
| Cardiovascular | Stage 1 HTN, Stage 2 HTN + DM + Nephropathy, Stable Angina |
| Endocrine | T2DM (new), Hypothyroidism, Hyperthyroidism (Graves') |
| Respiratory | Bronchial Asthma (GINA Step 2), COPD (GOLD B), Community-Acquired Pneumonia |
| Gastrointestinal | GERD (erosive), Peptic Ulcer + H. pylori, IBS-D |
| Musculoskeletal | Rheumatoid Arthritis, Osteoarthritis Knee, Acute Gout |
| Neurology | Migraine, Epilepsy (generalized) |
| Psychiatry | Major Depressive Disorder, Generalized Anxiety Disorder |
| Urology/Nephrology | Uncomplicated UTI, Benign Prostatic Hyperplasia |
| Hematology | Iron Deficiency Anemia, Vitamin B12 Deficiency |
| Dermatology | Plaque Psoriasis, Acne Vulgaris (moderate) |
| ENT | Allergic Rhinitis, Streptococcal Tonsillitis |
| Orthopedics | Acute Low Back Pain |
| Infectious Disease | Pulmonary Tuberculosis |
| Geriatrics | Polypharmacy/Medication Review (Beers Criteria) |
Each prescription follows real-world format with drug name, dose, frequency, duration, and critical counselling points. A monitoring table and red flag reference guide are included at the end for quick OPD use.